Trials / Completed
CompletedNCT06132269
Evaluation the Effect of AKK Formula on Intestinal Microbiota Regulation and Body Composition
- Status
- Completed
- Phase
- N/A
- Study type
- Interventional
- Enrollment
- 70 (actual)
- Sponsor
- TCI Co., Ltd. · Industry
- Sex
- All
- Age
- 18 Years – 65 Years
- Healthy volunteers
- Accepted
Summary
The AKK formula, a prebiotic blend, can effectively promote the proliferation of A. muciniphila. In this study, we attempt to explore the clinical efficacy of AKK formula for A. muciniphila proliferation and weight management.
Detailed description
This is a double-blind, randomized, parallel and placebo-controlled study. Subjects are informed to consume the samples daily for 8 weeks. The person who is evaluated as obesity by the investigator will be invited to participate in this trial. In this study, we attempt to explore the clinical efficacy of AKK formula for A. muciniphila proliferation and weight management.
Conditions
Interventions
| Type | Name | Description |
|---|---|---|
| DIETARY_SUPPLEMENT | AKK formula prebiotic sachet | 5 g/sachet, containing AKK formula, Indigestible Maltodextrin, Crystalline Maltitol, Calcium Carbonate, Citric Acid, Steviol Glycosides, and flavor. Subjects will consume 1 sachet per day for 8 weeks. |
| DIETARY_SUPPLEMENT | Placebo sachet | 5 g/sachet, containing Indigestible Maltodextrin, Crystalline Maltitol, Calcium Carbonate, Citric Acid, Steviol Glycosides, and flavor. Subjects will consume 1 sachet per day for 8 weeks. |
Timeline
- Start date
- 2023-11-09
- Primary completion
- 2024-01-30
- Completion
- 2024-05-01
- First posted
- 2023-11-15
- Last updated
- 2024-05-06
Locations
1 site across 1 country: Taiwan
Source: ClinicalTrials.gov record NCT06132269. Inclusion in this directory is not an endorsement.